Syndrome:  Pneumonia, community acquired - inpatient, ICU, pseudomonas

Primary Therapy(s):

  • (Cefepime 2gm IV q8 or Pip/tazo 4.5 gm IV q 6 or Imipenem/Meropenem) + (Cipro 400 mg IV q12 or levofloxacin 750 mg qd)

Alternate Therapy(s):

  • (Pip/tazo or Cefepime or Imipenem/ Meropenem) + Tobramycin + Azithromycin
  • Aztreonam + (Levofloxacin or Moxifloxacin)

Comments: Add vancomycin (or linezolid) for MRSA risk



Guideline Index         Guideline Table  

2nd generation cephalosporins--Cefuroxime, Cefpodoxime
Respiratory quionlones--Levofloxacin, Moxifloxacin